Showing 145,041 - 145,060 results of 224,509 for search '(( a ((laser decrease) OR (a decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 2.11s Refine Results
  1. 145041

    Image_1_Prolactin does not seem to mediate the improvement on insulin resistance markers and blood glucose levels related to breastfeeding.jpeg by Julia Martins de Oliveira (16903563)

    Published 2023
    “…</p>Methods<p>The prospective study followed 95 women older than 18 years from early pregnancy for up to 60 to 180 days postpartum. All participants had a BMI > 25 kg/m<sup>2</sup> and a singleton pregnancy. …”
  2. 145042

    Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  3. 145043

    Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  4. 145044

    Bias risk assessment for individual studies. by Xiaoqi Wu (9503481)

    Published 2023
    “…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”
  5. 145045

    Sustained-release of phages targets <i>E</i>. <i>faecalis</i> biofilm. by Mor Shlezinger (4897351)

    Published 2019
    “…<p><b>(A) <i>E</i>. <i>faecalis</i> biofilm biomass decreased following treatment with sustained-release EFDG1/EFLK1 phage cocktail.…”
  6. 145046

    Data_Sheet_2_Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer A... by Gurbet Tutumlu (8691720)

    Published 2020
    “…In the first approach, a molecular docking and filtering approach is used to rank compounds based on their docking scores and only a few top-ranked molecules are selected for further long (100-ns) molecular dynamics (MD) simulations and in vitro tests. …”
  7. 145047

    The Effect of Symmetric and Asymmetric NHCs on the Structure and Catalytic Properties of Dialkylgallium Alkoxides in the Ring-Opening Polymerization of <i>rac</i>-LactideLinking t... by Anna Maria Dąbrowska (1859476)

    Published 2021
    “…The much smaller cavity of <b>4</b> led to a minor activity and lower isoselectivity (<i>P</i><sub>m‑max</sub> = 0.56 at −20 °C). …”
  8. 145048

    Expression of mesoderm and primitive streak markers in <i>Cul4b</i>-null embryos. by Chun-Yu Chen (486495)

    Published 2019
    “…(C, D) A slight decrease in Brachyury was detected at E7.5 in <i>Cul4b</i><sup><i>Δ/</i></sup><i>Y</i> embryos. …”
  9. 145049

    Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  10. 145050

    Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  11. 145051

    Subgroup analysis of angina pectoris attack time. by Xiaoqi Wu (9503481)

    Published 2023
    “…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”
  12. 145052

    Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  13. 145053

    Retinoic acid signaling responsiveness in the periocular region. by Glenda Evangelina Comai (9652709)

    Published 2020
    “…BMS493 treatment before and after tamoxifen induction reveals a drastic decrease in GFP+ cells in the periocular region (<b>I</b>) compared with controls (<b>G</b>). …”
  14. 145054

    Safety and EEG data quality of concurrent high-density EEG and high-speed fMRI at 3 Tesla by Mette Thrane Foged (4050703)

    Published 2017
    “…The degree of artifacts and the ability to identify background activity was assessed by visual analysis by a trained expert in the 64 channel EEG data (7 healthy controls, 13 patients).…”
  15. 145055

    Meta-analysis off requency of angina attacks. by Xiaoqi Wu (9503481)

    Published 2023
    “…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”
  16. 145056

    Flow of patients in Halos trial. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  17. 145057

    Meta-analysis of angina pectoris attack time. by Xiaoqi Wu (9503481)

    Published 2023
    “…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”
  18. 145058

    Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  19. 145059

    Supplementary Figures from Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells by Xueheng Zhao (7024310)

    Published 2023
    “…*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 (two-tailed t test) Supplementary Figure 5 Ganglioside GM3 (d34:1), GM3 (d34:0) and GM3 (d34:2) decrease in NTsh, FANCD2sh and FANCJsh UMSCC-1 cells after NB-DNJ exposure Supplementary Figure 6 NTsh and FANCD2sh NIKS cells (a) and UMSCC-47 cells (b) were plated at equal cell numbers, and NB-DNJ was added following cell attachment, and replenished in fresh media after 24 hrs</p>…”
  20. 145060

    Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”